Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)

Go back to Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Bristol-Myers Squibb (NYSE: BMY) Delayed: 67.01 +1.54 (2.35%)
Previous Close $65.47    52 Week High $77.12 
Open $65.79    52 Week Low $49.03 
Day High $67.55    P/E 43.51 
Day Low $65.13    EPS $1.54 
Volume 7,932,248       

Gilead Sciences (NASDAQ: GILD) Delayed: 146.12 +2.68 (1.87%)
Previous Close $143.44    52 Week High $108.63 
Open $144.52    52 Week Low $71.39 
Day High $147.91    P/E 80.73 
Day Low $143.50    EPS $1.81 
Volume 5,384,399       

Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) Delayed: 24.50 --0 (-0%)
Previous Close $24.50    52 Week High $24.50 
Open $9.18    52 Week Low $4.81 
Day High $24.50    P/E N/A 
Day Low $24.50    EPS $-0.89 
Volume 5,300       

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 548.05 +7.79 (1.44%)
Previous Close $540.26    52 Week High $134.71 
Open $545.10    52 Week Low $73.31 
Day High $555.32    P/E N/A 
Day Low $540.70    EPS $-1.98 
Volume 1,074,988